Denmosis Pharma Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2024.
2024 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Denmosis Pharma Private Limited

Denmosis Pharma Private Limited, a active private limited company, was established on 11 December 2024 in Mumbai, Maharashtra, India. it holds CIN: U46497MH2024PTC436282. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Wasim Ahmed Abdul Latif Shaikh (Director), Nadeem Ahmed Mohd Shakil Qureshi (Director), Shahban Husen Karam Husen (Director). Past directors included Arohi Singh Sharma, Jamshed Alam. Its latest AGM occurred on 31 December 2025, with the balance sheet filed on 31 March 2025. It is based at R.N.3, 1St Flr, Jaffar, Compound Sakinaka Kurla W, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MH2024PTC436282

  • Registration Number

    436282

  • Incorporation Date

    11 December 2024

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Denmosis Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Denmosis Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Denmosis Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Wasim Ahmed Abdul Latif Shaikh Director 11 Dec 2024 Current
Nadeem Ahmed Mohd Shakil Qureshi Director 11 Dec 2024 Current
Shahban Husen Karam Husen Director 11 Dec 2024 Current
Arohi Singh Sharma Director 11 Jun 2025 Current
Jamshed Alam Individual Subscriber 11 Dec 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Dec 2025 Past
Pramod Abcsdd Additional Director 30 Dec 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Denmosis Pharma.
Denmosis Pharma revenue growth over time
Denmosis Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Denmosis Pharma?

Unlock access to Denmosis Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Denmosis Pharma?

Unlock and access historical data on people associated with Denmosis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Denmosis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denmosis Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Denmosis Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Denmosis Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Arohi Singh Sharma was appointed as a Director was appointed as a Director on 11 Jun 2025 & has been associated with this company since 9 months 7 days . was completed.

  • Balance Sheet

    The activity Denmosis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was completed.

  • Director Appointment

    Wasim Ahmed Abdul Latif Shaikh was appointed as a Director was appointed as a Director on 11 Dec 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    Nadeem Ahmed Mohd Shakil Qureshi was appointed as a Director was appointed as a Director on 11 Dec 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    Shahban Husen Karam Husen was appointed as a Director was appointed as a Director on 11 Dec 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Denmosis Pharma Private Limited?

The CIN of Denmosis Pharma Private Limited is U46497MH2024PTC436282.

Where is Denmosis Pharma Private Limited headquartered?

Denmosis Pharma Private Limited is headquartered at R.N.3, 1St Flr, Jaffar, Compound Sakinaka Kurla W, Mumbai, Maharashtra, 400072.

When was Denmosis Pharma Private Limited incorporated?

Denmosis Pharma Private Limited was incorporated on 11 December 2024.

Who are the current directors of Denmosis Pharma Private Limited?

The current directors of Denmosis Pharma Private Limited are

Is Denmosis Pharma Private Limited a listed company?

Denmosis Pharma Private Limited is unlisted.

What is the capital structure of Denmosis Pharma Private Limited?

The authorized capital of Denmosis Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available